This is a news story, published by Wired, that relates primarily to FDA news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Wired, you can click here:
more news from WiredOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
oral phenylephrine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest nasal decongestant news, counter decongestant news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
phenylephrineWired
•
72% Informative
The US Food and Drug Administration formally began the process of abandoning oral phenylephrine, a common over-the-counter decongestant that the agency concluded last year is not effective at relieving stuffy noses.
The FDA issued a proposed order Thursday to remove oral Phenylephrine from the list of drugs that drugmakers can include in OTC products.
For now, the order is just a proposal; the FDA will open up a public comment period.
VR Score
72
Informative language
76
Neutral language
18
Article tone
formal
Language
English
Language complexity
59
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
6
Source diversity
4
Affiliate links
no affiliate links